首页> 外文OA文献 >Multiple biomarkers biosensor with just-in-time functionalization: Application to prostate cancer detection
【2h】

Multiple biomarkers biosensor with just-in-time functionalization: Application to prostate cancer detection

机译:具有即时功能的多种生物标志物生物传感器:在前列腺癌检测中的应用

摘要

We present a novel lab-on-a-chip (LOC) device for the simultaneous detection of multiple biomarkers using simple voltage measurements. The biosensor functionalization is performed in-situ, immediately before its use, facilitating reagents storage and massive devices fabrication. Sensitivity, limit of detection (LOD) and limit of quantification (LOQ) are tunable depending on the in-chip flown sample volumes. As a proof-of-concept, the system has been tested and adjusted to quantify two proteins found in blood that are susceptible to be used combined, as a screening tool, to diagnose prostate cancer (PCa): prostate-specific antigen (PSA) and spondin-2 (SPON2). This combination of biomarkers has been reported to be more specific for PCa diagnostics than the currently accepted but rather controversial PSA indicator. The range of detection for PSA and SPON2 could be adjusted to the clinically relevant range of 1 to 10. ng/ml. The system was tested for specificity to the evaluated biomarkers. This multiplex system can be modified and adapted to detect a larger quantity of biomarkers, or different ones, of relevance to other specific diseases.
机译:我们提出了一种新颖的芯片实验室(LOC)设备,可使用简单的电压测量同时检测多个生物标志物。生物传感器功能化是在使用前就地进行的,从而有助于试剂的存储和大量设备的制造。灵敏度,检测限(LOD)和定量限(LOQ)可以根据芯片上飞行的样品量进行调整。作为概念验证,该系统已经过测试和调整,以量化在血液中发现的两种易于使用的蛋白质,作为诊断前列腺癌(PCa)的筛选工具,它们是:前列腺特异性抗原(PSA)和spondin-2(SPON2)。据报道,这种生物标志物组合对PCa诊断的特异性比目前接受的但颇具争议的PSA指示器更重要。 PSA和SPON2的检测范围可以调整为1至10 ng / ml的临床相关范围。测试了系统对所评估生物标志物的特异性。可以对该多重系统进行修改并使其适合于检测与其他特定疾病相关的大量生物标志物或不同的生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号